What is the concern with using ibrutinib in treatment?
One major concern with using ibrutinib in treatment is the potential for a range of side effects, including bleeding, infections, and an increased risk of developing other cancers. Additionally, some patients may experience drug resistance or intolerance to ibrutinib, leading to the need for alternative treatments. Regular monitoring and communication with healthcare providers are essential to manage these potential risks and ensure the best possible outcomes for patients receiving ibrutinib therapy.
This mind map was published on 17 May 2024 and has been viewed 60 times.
